Spectral Instruments Imaging ads

Join us for our upcoming webinar exploring how genome-wide CRISPR-based genetic screens are transforming the development of next-generation CAR T cell therapies. Despite significant advances in treating certain blood cancers, challenges such as T cell exhaustion and limited efficacy in solid tumors continue to impact patient outcomes. Dr. Cosmas Arnold will discuss how advanced screening technologies are helping researchers uncover key regulators of CAR T cell function and identify novel therapeutic targets. Learn how these powerful approaches are accelerating the engineering of more potent, durable, and effective cell therapies for the future of cancer treatment. 🗓️ Thursday, November 19, 7:00 AM PT / 10:00 AM ET / 4:00 PM CET

Watch our on-demand webinar exploring the fundamentals of fluorescence-based non-invasive whole-body imaging and its applications in preclinical research. We discuss the basics of fluorescence screening, optimization, and related probe selection, as well as opportunities to incorporate fluorescent imaging into multimodal screening approaches, along with the advantages and limitations of fluorescence-based non-invasive imaging screens. In vivo and ex vivo examples from inflammatory, infectious, and other murine models of human disease will highlight the value of fluorescent modalities in whole-body imaging studies.

Join us for our upcoming webinar exploring the fundamentals of fluorescence-based non-invasive whole-body imaging and its applications in preclinical research. We'll discuss the basics of fluorescence screening, optimization, and related probe selection, as well as opportunities to incorporate fluorescent imaging into multimodal screening approaches, along with the advantages and limitations of fluorescence-based non-invasive imaging screens. In vivo and ex vivo examples from inflammatory, infectious, and other murine models of human disease will highlight the value of fluorescent modalities in whole-body imaging studies. 🗓 Tuesday, September 22 | 9:00 AM PDT / 12:00 PM EDT

In this on-demand webinar, co-hosted with EnquBio, we highlight an optimized immune-competent MB49-Luc orthotopic bladder cancer model designed for non-invasive longitudinal imaging. This session explores the methodology behind the model, including how improved consistency and extended study windows can help researchers monitor tumor progression and therapeutic response over time using bioluminescence imaging.

Join us live as we explore how immune-competent orthotopic bladder cancer models and real-time bioluminescence imaging are helping advance smarter, more translational preclinical oncology research. We’ll discuss how the MB49-Luc model enables non-invasive monitoring of tumor growth and treatment response, while supporting immunotherapy studies in a biologically relevant tumor microenvironment.

Better data. Fewer animals. See how in vivo imaging can reduce animal use while improving statistical power and translational relevance. Join this on-demand webinar to explore today’s key preclinical imaging technologies in the context of reduction and refinement goals.